Incyte
INCY
113.44
+0.71
+0.63%
Incyte
US · INCY
#803 by market cap
Listed 1970
113.44
+0.71
+0.63%
Live - 5344 symbols - heartbeat 212s ago
· 2026-10-08 07:46
Pre-market
113.00
-0.39%
After-hours
111.97
-1.30%
Overnight
113.45
+0.01%
- Market cap
- 22.99B
- P/E (TTM)i
- 14.45
- P/Bi
- 3.62
- EPSi
- 6.41
- Div yieldi
- 0.00%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on INCY?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $150 Price TargetBenzinga · 2026/8/3
-
HC Wainwright & Co. Maintains Buy on Incyte, Raises Price Target to $152Benzinga · 2026/9/28
-
Company notice
4: Incyte | 4: Statement of changes in beneficial ownership of securities-Officer Hoffman Richard A.SEC · 2026/7/21
-
Company notice
Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LPSEC · 2026/5/12
-
Rating change
BMO Capital Upgrades Incyte(INCY.US) to Hold Rating, Raises Target Price to $130Market Newswire · 2026/7/29
-
H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $152Market Newswire · 2026/9/28
-
Rating change
Mizuho Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $137Market Newswire · 2026/8/3
-
Company notice
4: Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LPSEC · 2026/7/3
-
H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $150Market Newswire · 2026/9/1
-
H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152Market Newswire · 2026/9/29
-
Rating change
CCORF Initiates Incyte(INCY.US) With Buy Rating, Announces Target Price $152Market Newswire · 2026/8/20
-
Rating change
H.C. Wainwright Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $150Market Newswire · 2026/7/30
-
Company notice
Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LPSEC · 2026/4/3
-
BMO Capital Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $130Market Newswire · 2026/9/1
-
Rating change
William Blair Maintains Incyte(INCY.US) With Hold RatingMarket Newswire · 2026/8/20
-
Rating change
Piper Sandler Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $130Market Newswire · 2026/8/17
-
Rating change
Leerink Partners Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $155Market Newswire · 2026/8/3
-
Rating change
CCORF Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $152Market Newswire · 2026/8/21
-
Company notice
4: Incyte | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LPSEC · 2026/6/11
-
Rating change
Truist Financial Maintains Incyte(INCY.US) With Hold RatingMarket Newswire · 2026/7/29
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:46:26 · For reference only, not investment advice and not tailored to your situation.